Recall: D-0235-2022

Class III - Minor Violations

Class IIIClassification

2021-10-28Initiated

TerminatedStatus

Teva Pharmaceuticals USAFirm

Product

Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 0591-3508-04

Reason

Failed Impurities/Degradation Specifications

Distribution

Nationwide and Puerto Rico

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.